CO

Global Cord Bloo
NYSE

Real-time Quotes | Nasdaq Last Sale

4.550
-0.240
-5.01%
Closed 16:00 03/08 EST
OPEN
4.790
PREV CLOSE
4.790
HIGH
4.790
LOW
4.500
VOLUME
310.76K
TURNOVER
--
52 WEEK HIGH
4.980
52 WEEK LOW
2.540
MARKET CAP
554.27M
P/E (TTM)
7.44
1D
5D
1M
3M
1Y
5Y
Alternate Ocean Investment proposes to acquire Global Cord Blood for $5/share
Alternate Ocean Investment, a wholly-owned subsidiary of Haitong International Securities (HTNGF) has made an offer to Global Cord Blood (CO) to acquire all of the outstanding ordinary shares for $5/share in
Seekingalpha · 6d ago
RKT, SOS, KOPN and PERI among premarket gainers
NanoViricides (NNVC) +112% on effectiveness of COVID-19 drug candidates in cell culture studies.Communications Systems (JCS) +38% after entering merger agreement with Pineapple Energy.STRATA Skin Sciences (SSKN) +30% on announcing CEO Transition.CHF Soluti...
Seekingalpha · 6d ago
BRIEF-Global Cord Blood Corp Announces Receipt Of Unsolicited Non-Binding Acquisition Proposal
reuters.com · 6d ago
Global Cord Blood Corporation Announces Receipt of Unsolicited Non-Binding Acquisition Proposal
Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its board of directors (the "...
PR Newswire · 6d ago
China Cord Blood Receives $5 per Share Takeover Bid From Haitong International Securities Group Unit
MT Newswires · 6d ago
Global Cord Blood Corp. to Host Earnings Call
February 25, 2021 (ACCESSWIRE via COMTEX) -- NEW YORK, NY / ACCESSWIRE / February 25, 2021 / Global Cord Blood Corp. (NYSE:CO) will be discussing their...
ACCESSWIRE · 02/25 11:15
BRIEF-Global Cord Blood Corp Reports Q3 Financial Results
reuters.com · 02/24 21:26
Global Cord Blood reports Q3 results
Global Cord Blood (CO): Q3 GAAP EPS of $0.15.Revenue of $44.6MPress Release
Seekingalpha · 02/24 21:26
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CO. Analyze the recent business situations of Global Cord Bloo through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CO stock price target is 15.00 with a high estimate of 15.00 and a low estimate of 15.00.
EPS
Institutional Holdings
Institutions: 58
Institutional Holdings: 23.04M
% Owned: 18.95%
Shares Outstanding: 121.55M
TypeInstitutionsShares
Increased
8
21.43K
New
5
-84.16K
Decreased
9
298.64K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.78%
Healthcare Providers & Services
+1.00%
Key Executives
Chairman/Chief Executive Officer/Director
Ting Zheng
Chief Financial Officer/Director
Albert Chen
Corporate Executive
Rui Arashiyama
Chief Technology Officer
Xin Xu
Non-Executive Director
Ping Xu
Non-Executive Independent Director
Mark Chen
Non-Executive Independent Director
Siu Chuen Cheng
Non-Executive Independent Director
Jack Chow
Non-Executive Independent Director
Ken Lu
Non-Executive Independent Director
Jennifer Weng
Declaration Date
Dividend Per Share
Ex-Div Date
06/26/2018
Dividend USD 0.08
07/27/2018
About CO
Global Cord Blood Corporation, formerly China Cord Blood Corporation, is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.

Webull offers kinds of Global Cord Blood Corp stock information, including NYSE:CO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CO stock methods without spending real money on the virtual paper trading platform.